BioPharma Dive 20. Apr. 2026 AACR 2026: Revolution’s next prospect, Merck’s reveal and a lung cancer battle
BioPharma Dive 12. Feb. 2026 Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo